Skip to content

Effectiveness and Safety for Non-invasive Neuromodulation for Treating Essential Tremor

Effectiveness and Safety for Non-invasive Neuromodulation for Treating Essential Tremor

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111084
Enrollment
Unknown
Registered
2025-10-24
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Tremor

Interventions

Intervention group:Patients wear low-frequency therapy devices for 40 minutes.
control:Patients wear the low-frequency therapy device for 40 minutes, but it was pre-set to non-operational mode.

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Be aged >=18 years and =2 points on any single item are eligible for inclusion.

Exclusion criteria

Exclusion criteria: 1. Implantation of a brain pacemaker or cardiac pacemaker 2. History of thalamotomy 3. Epilepsy 4. Current treatment with botulinum toxin for upper limb tremor 5. Presence of upper limb rash, skin lesions, open wounds, skin infections, skin tumours, or haemangiomas 6. Upper limb neurological pathology in the subject; 7. Known allergy to any component of the product (e.g., silicone, cotton textiles); 8. Pregnant women; 9. Caffeine intake or significant alcohol consumption within 8 hours prior to enrolment; 10. Patients with concomitant psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Idiopathic Tremor Rating Scale Scores Before and After Stimulation;

Secondary

MeasureTime frame
Self-reported scores on the Bain & Findley Activities of Daily Living Scale (BF-ADL) before and after stimulation;Clinical and Patient Global Impression scores after stimulation;

Countries

China

Contacts

Public ContactHe Mianwang

Chinese PLA General Hospital

hemianwang@126.com+86 135 2122 4871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026